The Russian Ministry of Health has registered the pharmaceutical…

The Russian Ministry of Health has registered the pharmaceutical product 'Nimolancin' for the treatment of adults with a range of malignant tumors, including esophageal cancer, head and neck cancers, and certain types of malignant brain tumors, according to the ministry's press service.

Coverage (6 sources)

Key entities